Cargando…

Efficacy, Tolerability, and Safety of Oxybutynin Chloride in Pediatric Neurogenic Bladder With Spinal Dysraphism: A Retrospective, Multicenter, Observational Study

PURPOSE: Anticholinergics are a key element in treating neurogenic detrusor overactivity, but only limited data are available in the pediatric population, thus limiting the application to children even for oxybutynin chloride (OC), a prototype drug. This retrospective study was designed to provide d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jung Hoon, Kim, Kyoung Rok, Lee, Yong Seung, Han, Sang Won, Kim, Kun Suk, Song, Sang Hoon, Baek, Minki, Park, Kwanjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265718/ https://www.ncbi.nlm.nih.gov/pubmed/25512818 http://dx.doi.org/10.4111/kju.2014.55.12.828

Ejemplares similares

Long-Term Efficacy, Safety, and Tolerability of Modified Intravesical Oxybutynin Chloride for Neurogenic Bladder in Children
por: Honda, Masashi, et al.
Publicado: (2019)

Profiling the Urobiota in a Pediatric Population with Neurogenic Bladder Secondary to Spinal Dysraphism
por: De Maio, Flavio, et al.
Publicado: (2023)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2014)

Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with Overactive Bladder: A Multicenter Retrospective Study
por: Park, Se Jin, et al.
Publicado: (2015)

Atypical aquagenic keratoderma treated with oxybutynin chloride
por: Dixit, Niharika, et al.
Publicado: (2018)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Neurogenic Lower Urinary Tract Dysfunction in Spinal Dysraphism: Morphological and Molecular Evidence in Children
por: Planta, Dafni, et al.
Publicado: (2023)

Spinal dysraphism
por: Venkataramana, N. K.
Publicado: (2011)

Spinal dysraphism
por: Perumal, Vinoth Kumar, et al.
Publicado: (2020)

Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)

Preoperative Videourodynamic Study Is Helpful in Predicting Long-term Postoperative Voiding Function in Asymptomatic Patients With Closed Spinal Dysraphism
por: Kim, Louis, et al.
Publicado: (2022)

Reoperation in Spinal Dysraphism
por: Mohanty, Aaron
Publicado: (2017)

Intraoperative Neurophysiology Monitoring for Spinal Dysraphism
por: Kim, Keewon
Publicado: (2021)

Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gel
por: Sand, Peter K, et al.
Publicado: (2011)

Analysis of Risk Factors and Management of Cerebrospinal Fluid Morbidity in the Treatment of Spinal Dysraphism
por: Lee, Byung-Jou, et al.
Publicado: (2013)

Unusual Spinal Dysraphic Lesions
por: Tude Melo, Jose Roberto, et al.
Publicado: (2013)

Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats
por: Cho, Young-Sam, et al.
Publicado: (2014)

Patient perspectives in the management of overactive bladder, focus on transdermal oxybutynin
por: Gamble, Tondalaya, et al.
Publicado: (2008)

Enlargement of Extraspinal Cysts in Spinal Dysraphism : A Reason for Early Untethering
por: Kim, Kyung Hyun, et al.
Publicado: (2020)

Cutaneous Stigmata of Occult Spinal Dysraphism
por: Kumar Sarin, Yogesh
Publicado: (2013)

Spinal dysraphism illustrated; Embroyology revisited
por: Acharya, Ullas V, et al.
Publicado: (2017)

Oxybutynin extended release for the management of overactive bladder: a clinical review
por: Arisco, AM, et al.
Publicado: (2009)

Oxybutynin and Tolterodine in a Trial for Treatment of Overactive Bladder in Iranian Women
por: Aziminekoo, Elham, et al.
Publicado: (2014)

Insights into the Management of Overactive Bladder with Transdermal Oxybutynin: A Practical Review
por: Vozmediano-Chicharro, Raúl, et al.
Publicado: (2020)

Clinical and Economic Evaluation of Transdermal Oxybutynin in the Treatment of Overactive Bladder in Spain
por: Crespo, Carlos, et al.
Publicado: (2018)

The Effectiveness of Intravesical Oxybutynin, Propantheline, and Capsaicin in the Management of Neuropathic Bladder following Spinal Cord Injury
por: George, Jacob, et al.
Publicado: (2007)

Reduction of transverse rectal diameter and its effect on bladder dynamics in children with spinal dysraphism
por: Radojicic, Zoran, et al.
Publicado: (2022)

Methadone-Induced Hyperhidrosis Treated With Oxybutynin
por: Hong, Joe, et al.
Publicado: (2017)

Radiofrequency Sacral Rhizotomy for the Management of Intolerable Neurogenic Bladder in Spinal Cord Injured Patients
por: Cho, Kang Hee, et al.
Publicado: (2012)

Phasic Changes in Bladder Compliance During Filling Cystometry of the Neurogenic Bladder
por: Kim, Soo-Yeon, et al.
Publicado: (2014)

Association of bladder trabeculation and neurogenic bladder with spinal cord injury
por: Won, Yu Hui, et al.
Publicado: (2022)

Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

Intravesical Oxybutynin for Urgent Bladder Rescue in a Newborn with Posterior Urethral Valves
por: Molina Caballero, Ada, et al.
Publicado: (2019)

Intraspinal Lipomas Without Associated Spinal Dysraphism
por: Arslan, Erhan, et al.
Publicado: (2014)

Diastematomyelia with hemimyelomeningocele: An exceptional and complex spinal dysraphism
por: Singh, Neha, et al.
Publicado: (2015)

Cervical myelocystocele: rare presentation of spinal dysraphism
por: Mugarab Samedi, Veronica, et al.
Publicado: (2018)

Perspectives on Spinal Dysraphism : Past, Present, and Future
por: Pang, Dachling
Publicado: (2020)

Cervicothoracic Spinal Dysraphism: Unravelling the Pandora’s Box
por: Mehrotra, Anant, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fke4369m30pjmevf53fr00i13m